Pfizer Limited (BOM:500680)

Lumos Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 5, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	229,654	183,197	191,909	158,614	198,918	207,004
Market Cap Growth	-4.54%	-4.54%	20.99%	-20.26%	-3.91%	12.48%
Enterprise Value	202,911	161,131	174,148	144,499	184,772	197,991
Last Close Price	5031.05	3891.04	4051.02	3313.11	4098.04	4232.83
PE Ratio	29.92	23.87	34.81	25.42	32.47	41.60
PS Ratio	10.07	8.03	8.75	6.54	7.62	9.24
PB Ratio	5.45	4.34	5.34	4.95	6.94	8.65
P/TBV Ratio	6.27	5.00	6.33	6.02	8.87	12.03
P/FCF Ratio	36.36	29.01	80.67	54.56	30.52	50.53
P/OCF Ratio	34.81	27.77	74.72	44.60	29.82	48.44
EV/Sales Ratio	8.89	7.06	7.94	5.96	7.08	8.84
EV/EBITDA Ratio	27.43	22.85	29.10	18.76	23.45	29.56
EV/EBIT Ratio	29.79	23.66	30.18	20.51	25.58	32.75
EV/FCF Ratio	32.13	25.51	73.20	49.71	28.35	48.33
Debt / Equity Ratio	0.03	0.03	0.03	0.04	0.06	0.05
Debt / EBITDA Ratio	0.15	0.15	0.15	0.17	0.20	0.16
Debt / FCF Ratio	0.17	0.17	0.40	0.46	0.26	0.27
Asset Turnover	0.50	0.50	0.53	0.61	0.73	0.58
Inventory Turnover	1.79	1.79	1.88	2.03	2.16	1.86
Quick Ratio	5.26	5.26	4.15	3.10	2.19	1.82
Current Ratio	6.17	6.17	5.07	3.84	2.77	2.47
Return on Equity (ROE)	19.65%	19.65%	16.21%	20.55%	23.30%	17.19%
Return on Assets (ROA)	9.32%	9.32%	8.76%	11.15%	12.60%	9.85%
Return on Capital (ROIC)	10.62%	10.62%	10.26%	13.82%	16.31%	12.53%
Return on Capital Employed (ROCE)	15.70%	15.70%	15.70%	21.10%	23.70%	24.30%
Earnings Yield	3.34%	4.19%	2.87%	3.93%	3.08%	2.40%
FCF Yield	2.75%	3.45%	1.24%	1.83%	3.28%	1.98%
Dividend Yield	3.30%	0.90%	0.86%	1.06%	0.85%	0.71%
Payout Ratio	20.88%	20.88%	33.27%	27.22%	26.08%	20.06%
Buyback Yield / Dilution	-	-	0.01%	-	-	-
Total Shareholder Return	3.30%	0.90%	0.87%	1.06%	0.85%	0.71%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.